Myomo Company Leadership

Myomo Management Team Effectiveness

The company has Return on Asset of (0.2945) % which means that on every $100 spent on assets, it lost $0.2945. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (1.0051) %, meaning that it generated no profit with money invested by stockholders. Myomo's management efficiency ratios could be used to measure how well Myomo manages its routine affairs as well as how well it operates its assets and liabilities. As of the 11th of February 2026, Return On Tangible Assets is likely to drop to -0.14. In addition to that, Return On Capital Employed is likely to drop to -0.18. At this time, Myomo's Total Assets are very stable compared to the past year. As of the 11th of February 2026, Net Tangible Assets is likely to grow to about 7.7 M, while Other Assets are likely to drop about 589.3 K. As of the 11th of February 2026, Common Stock Shares Outstanding is likely to grow to about 45.6 M, while Net Loss is likely to drop (5.8 M). Myomo Inc maintains a total of 38.44 Million outstanding shares. Over half of Myomo's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Myomo in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Myomo, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Myomo Workforce Comparison

Myomo Profit Margins

The company has Net Profit Margin of (0.29) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.35) %, which entails that for every $100 of revenue, it lost $0.35.

Myomo Insider Trading

Myomo Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Myomo Inc often depends on how effective the management is. Myomo management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Myomo management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Myomo management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Understanding that Myomo's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Myomo represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Myomo's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.